Role of adjuvant radiotherapy after radical hysterectomy in node-negative stage IB-IIA cervical cancer with intermediate risk factors.
Identifieur interne : 003F23 ( Main/Merge ); précédent : 003F22; suivant : 003F24Role of adjuvant radiotherapy after radical hysterectomy in node-negative stage IB-IIA cervical cancer with intermediate risk factors.
Auteurs : Suphet Tuipae [Thaïlande] ; Marut Yanaranop ; Noppadol OniemSource :
- Journal of the Medical Association of Thailand = Chotmaihet thangphaet [ 0125-2208 ] ; 2012.
Descripteurs français
- KwdFr :
- Adulte d'âge moyen, Adénocarcinome (), Adénocarcinome (anatomopathologie), Adénocarcinome (mortalité), Adénocarcinome (radiothérapie), Carcinome épidermoïde (), Carcinome épidermoïde (anatomopathologie), Carcinome épidermoïde (mortalité), Carcinome épidermoïde (radiothérapie), Facteurs de risque, Femelle, Humains, Hystérectomie, Mâle, Radiothérapie adjuvante, Tumeurs du col de l'utérus (), Tumeurs du col de l'utérus (anatomopathologie), Tumeurs du col de l'utérus (mortalité), Tumeurs du col de l'utérus (radiothérapie).
- MESH :
- anatomopathologie : Adénocarcinome, Carcinome épidermoïde, Tumeurs du col de l'utérus.
- mortalité : Adénocarcinome, Carcinome épidermoïde, Tumeurs du col de l'utérus.
- radiothérapie : Adénocarcinome, Carcinome épidermoïde, Tumeurs du col de l'utérus.
- Adulte d'âge moyen, Adénocarcinome, Carcinome épidermoïde, Facteurs de risque, Femelle, Humains, Hystérectomie, Mâle, Radiothérapie adjuvante, Tumeurs du col de l'utérus.
English descriptors
- KwdEn :
- Adenocarcinoma (mortality), Adenocarcinoma (pathology), Adenocarcinoma (radiotherapy), Adenocarcinoma (surgery), Carcinoma, Squamous Cell (mortality), Carcinoma, Squamous Cell (pathology), Carcinoma, Squamous Cell (radiotherapy), Carcinoma, Squamous Cell (surgery), Female, Humans, Hysterectomy, Male, Middle Aged, Radiotherapy, Adjuvant, Risk Factors, Uterine Cervical Neoplasms (mortality), Uterine Cervical Neoplasms (pathology), Uterine Cervical Neoplasms (radiotherapy), Uterine Cervical Neoplasms (surgery).
- MESH :
- mortality : Adenocarcinoma, Carcinoma, Squamous Cell, Uterine Cervical Neoplasms.
- pathology : Adenocarcinoma, Carcinoma, Squamous Cell, Uterine Cervical Neoplasms.
- radiotherapy : Adenocarcinoma, Carcinoma, Squamous Cell, Uterine Cervical Neoplasms.
- surgery : Adenocarcinoma, Carcinoma, Squamous Cell, Uterine Cervical Neoplasms.
- Female, Humans, Hysterectomy, Male, Middle Aged, Radiotherapy, Adjuvant, Risk Factors.
Abstract
To assess the benefit of adjuvant radiotherapy after radical hysterectomy in node-negative FIGO stage IB-IIA cervical cancer patients with intermediate risk factors.
PubMed: 22619897
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 002118
- to stream PubMed, to step Curation: 002118
- to stream PubMed, to step Checkpoint: 002118
- to stream Ncbi, to step Merge: 004D99
- to stream Ncbi, to step Curation: 004D99
- to stream Ncbi, to step Checkpoint: 004D99
Links to Exploration step
pubmed:22619897Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Role of adjuvant radiotherapy after radical hysterectomy in node-negative stage IB-IIA cervical cancer with intermediate risk factors.</title>
<author><name sortKey="Tuipae, Suphet" sort="Tuipae, Suphet" uniqKey="Tuipae S" first="Suphet" last="Tuipae">Suphet Tuipae</name>
<affiliation wicri:level="1"><nlm:affiliation>Gynecologic Oncology Unit, Department of Obstetrics and Gynecology, Rajavithi Hospital, College of Medicine, Rangsit University, Bangkok, Thailand. suphetgyn@hotmail.com</nlm:affiliation>
<country xml:lang="fr">Thaïlande</country>
<wicri:regionArea>Gynecologic Oncology Unit, Department of Obstetrics and Gynecology, Rajavithi Hospital, College of Medicine, Rangsit University, Bangkok</wicri:regionArea>
<wicri:noRegion>Bangkok</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Yanaranop, Marut" sort="Yanaranop, Marut" uniqKey="Yanaranop M" first="Marut" last="Yanaranop">Marut Yanaranop</name>
</author>
<author><name sortKey="Oniem, Noppadol" sort="Oniem, Noppadol" uniqKey="Oniem N" first="Noppadol" last="Oniem">Noppadol Oniem</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2012">2012</date>
<idno type="RBID">pubmed:22619897</idno>
<idno type="pmid">22619897</idno>
<idno type="wicri:Area/PubMed/Corpus">002118</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002118</idno>
<idno type="wicri:Area/PubMed/Curation">002118</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002118</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002118</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002118</idno>
<idno type="wicri:Area/Ncbi/Merge">004D99</idno>
<idno type="wicri:Area/Ncbi/Curation">004D99</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">004D99</idno>
<idno type="wicri:doubleKey">0125-2208:2012:Tuipae S:role:of:adjuvant</idno>
<idno type="wicri:Area/Main/Merge">003F23</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Role of adjuvant radiotherapy after radical hysterectomy in node-negative stage IB-IIA cervical cancer with intermediate risk factors.</title>
<author><name sortKey="Tuipae, Suphet" sort="Tuipae, Suphet" uniqKey="Tuipae S" first="Suphet" last="Tuipae">Suphet Tuipae</name>
<affiliation wicri:level="1"><nlm:affiliation>Gynecologic Oncology Unit, Department of Obstetrics and Gynecology, Rajavithi Hospital, College of Medicine, Rangsit University, Bangkok, Thailand. suphetgyn@hotmail.com</nlm:affiliation>
<country xml:lang="fr">Thaïlande</country>
<wicri:regionArea>Gynecologic Oncology Unit, Department of Obstetrics and Gynecology, Rajavithi Hospital, College of Medicine, Rangsit University, Bangkok</wicri:regionArea>
<wicri:noRegion>Bangkok</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Yanaranop, Marut" sort="Yanaranop, Marut" uniqKey="Yanaranop M" first="Marut" last="Yanaranop">Marut Yanaranop</name>
</author>
<author><name sortKey="Oniem, Noppadol" sort="Oniem, Noppadol" uniqKey="Oniem N" first="Noppadol" last="Oniem">Noppadol Oniem</name>
</author>
</analytic>
<series><title level="j">Journal of the Medical Association of Thailand = Chotmaihet thangphaet</title>
<idno type="ISSN">0125-2208</idno>
<imprint><date when="2012" type="published">2012</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adenocarcinoma (mortality)</term>
<term>Adenocarcinoma (pathology)</term>
<term>Adenocarcinoma (radiotherapy)</term>
<term>Adenocarcinoma (surgery)</term>
<term>Carcinoma, Squamous Cell (mortality)</term>
<term>Carcinoma, Squamous Cell (pathology)</term>
<term>Carcinoma, Squamous Cell (radiotherapy)</term>
<term>Carcinoma, Squamous Cell (surgery)</term>
<term>Female</term>
<term>Humans</term>
<term>Hysterectomy</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Radiotherapy, Adjuvant</term>
<term>Risk Factors</term>
<term>Uterine Cervical Neoplasms (mortality)</term>
<term>Uterine Cervical Neoplasms (pathology)</term>
<term>Uterine Cervical Neoplasms (radiotherapy)</term>
<term>Uterine Cervical Neoplasms (surgery)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adulte d'âge moyen</term>
<term>Adénocarcinome ()</term>
<term>Adénocarcinome (anatomopathologie)</term>
<term>Adénocarcinome (mortalité)</term>
<term>Adénocarcinome (radiothérapie)</term>
<term>Carcinome épidermoïde ()</term>
<term>Carcinome épidermoïde (anatomopathologie)</term>
<term>Carcinome épidermoïde (mortalité)</term>
<term>Carcinome épidermoïde (radiothérapie)</term>
<term>Facteurs de risque</term>
<term>Femelle</term>
<term>Humains</term>
<term>Hystérectomie</term>
<term>Mâle</term>
<term>Radiothérapie adjuvante</term>
<term>Tumeurs du col de l'utérus ()</term>
<term>Tumeurs du col de l'utérus (anatomopathologie)</term>
<term>Tumeurs du col de l'utérus (mortalité)</term>
<term>Tumeurs du col de l'utérus (radiothérapie)</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Adénocarcinome</term>
<term>Carcinome épidermoïde</term>
<term>Tumeurs du col de l'utérus</term>
</keywords>
<keywords scheme="MESH" qualifier="mortality" xml:lang="en"><term>Adenocarcinoma</term>
<term>Carcinoma, Squamous Cell</term>
<term>Uterine Cervical Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="mortalité" xml:lang="fr"><term>Adénocarcinome</term>
<term>Carcinome épidermoïde</term>
<term>Tumeurs du col de l'utérus</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Adenocarcinoma</term>
<term>Carcinoma, Squamous Cell</term>
<term>Uterine Cervical Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="radiotherapy" xml:lang="en"><term>Adenocarcinoma</term>
<term>Carcinoma, Squamous Cell</term>
<term>Uterine Cervical Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="radiothérapie" xml:lang="fr"><term>Adénocarcinome</term>
<term>Carcinome épidermoïde</term>
<term>Tumeurs du col de l'utérus</term>
</keywords>
<keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Adenocarcinoma</term>
<term>Carcinoma, Squamous Cell</term>
<term>Uterine Cervical Neoplasms</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Female</term>
<term>Humans</term>
<term>Hysterectomy</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Radiotherapy, Adjuvant</term>
<term>Risk Factors</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte d'âge moyen</term>
<term>Adénocarcinome</term>
<term>Carcinome épidermoïde</term>
<term>Facteurs de risque</term>
<term>Femelle</term>
<term>Humains</term>
<term>Hystérectomie</term>
<term>Mâle</term>
<term>Radiothérapie adjuvante</term>
<term>Tumeurs du col de l'utérus</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">To assess the benefit of adjuvant radiotherapy after radical hysterectomy in node-negative FIGO stage IB-IIA cervical cancer patients with intermediate risk factors.</div>
</front>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003F23 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Merge/biblio.hfd -nk 003F23 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= Main |étape= Merge |type= RBID |clé= pubmed:22619897 |texte= Role of adjuvant radiotherapy after radical hysterectomy in node-negative stage IB-IIA cervical cancer with intermediate risk factors. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Merge/RBID.i -Sk "pubmed:22619897" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Merge/biblio.hfd \ | NlmPubMed2Wicri -a LymphedemaV1
This area was generated with Dilib version V0.6.31. |